Theranostic probes

Mitsunobu R. Kano

doi:10.2745/dds.26.386

Theranostic probes

Research output: Contribution to journal › Article › peer-review

Abstract

Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.

Original language	English
Pages (from-to)	386-391
Number of pages	6
Journal	Drug Delivery System
Volume	26
Issue number	4
DOIs	https://doi.org/10.2745/dds.26.386
Publication status	Published - Oct 31 2011
Externally published	Yes

Keywords

Contrast medium
Imaging
NanoDDS

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.2745/dds.26.386

Cite this

@article{4a281985dcc147e0afa8556fe5bc8e67,

title = "Theranostic probes",

abstract = "Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.",

keywords = "Contrast medium, Imaging, NanoDDS",

author = "Kano, {Mitsunobu R.}",

year = "2011",

month = oct,

day = "31",

doi = "10.2745/dds.26.386",

language = "English",

volume = "26",

pages = "386--391",

journal = "Drug Delivery System",

issn = "0913-5006",

publisher = "Japan Society of Drug Delivery System",

number = "4",

}

TY - JOUR

T1 - Theranostic probes

AU - Kano, Mitsunobu R.

PY - 2011/10/31

Y1 - 2011/10/31

N2 - Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.

AB - Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.

KW - Contrast medium

KW - Imaging

KW - NanoDDS

UR - http://www.scopus.com/inward/record.url?scp=80055114986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055114986&partnerID=8YFLogxK

U2 - 10.2745/dds.26.386

DO - 10.2745/dds.26.386

M3 - Article

AN - SCOPUS:80055114986

SN - 0913-5006

VL - 26

SP - 386

EP - 391

JO - Drug Delivery System

JF - Drug Delivery System

IS - 4

ER -

Theranostic probes

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this